Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: health insurance

Anti-TNF Treatment Tied to Lower Risk of Acute Arterial Events in IBD

Reuters Staff  |  September 25, 2019

NEW YORK (Reuters Health)—Anti-tumor necrosis factor (TNF) treatment is associated with a reduced risk of acute arterial events in patients with inflammatory bowel disease (IBD), especially men, new research shows. IBD patients face an increased risk of acute arterial events, which are also independently associated with disease activity, Julien Kirchgesner, MD, PhD, of Hospital Saint-Antoine,…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Anti-TNFanti-tumor necrosis factorbowelinflammatory bowel disease (IBD)

National Survey Highlights Rheumatology Patient Concerns, Challenges

Susan Bernstein  |  September 20, 2019

In a national survey of more than 1,500 Americans with rheumatic disease, more than half reported struggling to access affordable care and nearly two-thirds described challenges performing simple daily tasks.

Filed under:Patient Perspective Tagged with:patient perspectiveRheumatic Disease Awareness MonthSimple Tasks

Drug Assistance Programs Offer Little Charity to Uninsured

Lisa Rapaport  |  August 7, 2019

(Reuters Health)—Many patients who receive assistance from charities set up to defray prescription drugs costs may already have insurance that covers most the cost for their medications, a U.S. study suggests. Researchers examined data on the six largest independent charities offering patient assistance programs through 274 different disease-specific programs. These programs had total revenue ranging…

Filed under:Drug Updates Tagged with:drug accessMedicaidMedicareuninsured Americans

White House Scraps Proposal to Lower U.S. Drug Prices

Caroline Humer  |  July 14, 2019

(Reuters)—The Trump administration on Thursday scrapped one of its most ambitious proposals for lowering prescription medicine prices, backing down from a policy that would have required health insurers to pass on billions of dollars in rebates they receive from drugmakers to Medicare patients. The decision represents a new setback to President Donald Trump’s efforts to…

Filed under:Legislation & Advocacy Tagged with:drug pricing blueprintMedicareprescription drug pricesrebate reform initiativerebate ruleTrump administration

U.S. Appeals Court to Take Up Constitutionality of Obamacare

Nate Raymond  |  July 9, 2019

NEW ORLEANS (Reuters)—The future of Obamacare could be at stake on Tuesday when a coalition of Democratic-led states and House of Representatives urge a federal appeals court to overturn a Texas judge’s ruling that the U.S. healthcare reform law is unconstitutional. Republicans have repeatedly tried to repeal Obamacare, or the Affordable Care Act (ACA), since…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Affordable Care Act (ACA)Health InsuranceObamacare

Making Sense of Drug Pricing Legislation

From the College  |  July 2, 2019

A number of bills have been introduced in the 116th Congress to mitigate the impact of treatment and drug costs on U.S. patients. The ACR has reviewed the bills and supports those that most closely align with its positions on access to care.

Filed under:Drug UpdatesLegislation & AdvocacyProfessional Topics Tagged with:AdvocacyAmerican College of Rheumatology (ACR)drugLegislationrheumatology

Email & Text in the World of HIPAA

From the College  |  May 17, 2019

The world we live in necessitates infor­mation be communicated in a quick and easy manner. This remains true in the healthcare setting. The ability to text or email staff and patients has become a priority for many healthcare entities. However, maintaining patient privacy and confidentiality is essential to ensure we meet compliance standards. Although emailing…

Filed under:From the CollegePractice SupportTechnology Tagged with:emailHIPAAtext messaging

Trump Calls on Congress to Protect Patients from Surprise Medical Bills

Reuters Staff  |  May 9, 2019

WASHINGTON (Reuters)—U.S. President Donald Trump called on Congress on Thursday to pass legislation to protect patients from surprise medical bills from out-of-network doctors that can unnecessarily cost patients tens of thousands of dollars. In remarks at the White House, Trump unveiled principles the administration will send to congressional lawmakers to incorporate into a legislative package…

Filed under:Legislation & Advocacy Tagged with:out-of-network doctorssurprise medical bills

The RISE Registry Delivers Practice-Based Evidence to Rheumatologists

Nancy A. Baker, ScD, MPH, OT; Margarita Fallena, MD; Tracy Johansson, MS; Janell Martin, CAE; Kaleb Michaud, PhD; Cynthia S. Crowson, PhD; Dina L. Jones, PT, PhD  |  April 15, 2019

The advent of quality-based healthcare, such as the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), requires rheumatology professionals to demonstrate their practice is based on interventions supported by the best available evidence and that their practice, in turn, provides quality care. These requirements have increased the need for methods to measure and quantify…

Filed under:Quality Assurance/ImprovementResearch Rheum Tagged with:practice-based researchQualified Clinical Data Registries (QCDRs)Rheumatology Informatics System for Effectiveness (RISE) Registry

Kentucky Launches Probe into Drug Overcharges by Pharmacy Benefit Managers

Reuters Staff  |  March 25, 2019

(Reuters)—Kentucky Attorney General Andy Beshear said on Thursday he had launched an investigation into allegations that pharmacy benefit managers (PBMs) had overcharged state health insurance programs for drugs and discriminated against independent pharmacies. The investigation comes against the backdrop of widespread criticism of rising costs of prescription medicines in the United States, with PBMs, middlemen…

Filed under:Legal Updates Tagged with:Kentucky PBM probepharmacy benefit managers (PBMs)rising U.S. drug costs

  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 117
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences